Clinical trial

A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With…

NCT00236652 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed

Key facts

NCT number NCT00236652
Title A Study Evaluating the Safety and Efficacy of Treating Sinus Infection With Levofloxacin 750 mg for 5 Days.
Official title An Open-label, Multi-center, Non-comparative Sinus Puncture Study of 750 mg, Short-course Levofloxacin in the Treatment of Acute Maxillary Sinusitis
Lead sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry
Collaborators PriCara, Unit of Ortho-McNeil, Inc. Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Maxillary Sinusitis
Intervention type Drug
Interventions levofloxacin
Enrollment 18
Start date Nov 1, 2003
Completion Jun 1, 2005
First posted Oct 12, 2005
Last update posted Jun 10, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies